AbbVie Commits $1.4B to Build North Carolina Manufacturing Campus in Largest-Ever Site Investment

Marks AbbVie's largest-ever capital investment in a single campus since its inception Investment demonstrates continued progress a...

April 24, 2026 | Friday | News
10x Science Raises $4.8M Seed to Transform Molecular Protein Characterization with Explainable AI

10x Science, which builds frontier AI for molecular-level protein characterization across the life sciences, today announced the closing of its $4.8M seed ...

April 24, 2026 | Friday | News
Evonik Industries Commits €80M to Expand Biotechnology Capabilities at Slovenská Ľupča Fermas Site

Marks the second major investment at the Slovenská Ľupča site in recent years Follows the group’s strategy to strengthen leading ...

April 23, 2026 | Thursday | News
Thermo Fisher Scientific Expands PPD™ Clinical Research Capabilities Through Strategic Data Collaboration with HealthVerity

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD...

April 15, 2026 | Wednesday | News
U.S.–Taiwan Biopharma Ties Deepen as PharmaEssentia Corporation Launches Puerto Rico Expansion

A pivotal step in PharmaEssentia's dual-site U.S.-Taiwan manufacturing strategy, with 2027 operations in sight PharmaEssentia Corporation (TWS...

April 06, 2026 | Monday | News
H2 Global Group Accelerates MedTech Strategy, Expands Global Ambitions with VR LIFE and Hydrogen-Based Therapeutics

H2 Global Group is strengthening its position as a European technology group connecting capital with clinically validated healthcare innovations. A prime...

April 06, 2026 | Monday | News
Emergent BioSolutions Secures $54M U.S. Contract and Expands Global Orders for Smallpox Countermeasures

Emergent BioSolutions Inc. announced it has secured a contract award valued at approximately $54 million USD to deliver CNJ-016® [Vaccinia Immune Glo...

March 27, 2026 | Friday | News
Gilead to Acquire Ouro Medicines in $2.17B Deal to Expand Autoimmune T Cell Engager Portfolio

Gilead Sciences, Inc. (Nasdaq: GILD) announced  it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology...

March 25, 2026 | Wednesday | News
LGM Pharma Commits Additional $9M to CDMO Expansion, Scaling U.S. Manufacturing Capacity

— $9M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid,...

March 20, 2026 | Friday | News
Axplora Expands HPAPI Capabilities with $60M Investment to Accelerate High-Potency Drug Development

Highly potent drugs now account for over 30% of the global pipeline, with more than 1,000 molecules in development — Axplora’s investments in...

March 19, 2026 | Thursday | News
Agilent Technologies to Acquire Biocare Medical for $950 Million to Strengthen Global Pathology Portfolio

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit...

March 10, 2026 | Tuesday | News
UK Investment Zones Expand to Scotland to Accelerate Life Sciences Innovation

Two Investment Zones designated in Scotland to establish UK-wide Investment Zones network. Investment Zones with designated tax sites offer tax benefits...

March 09, 2026 | Monday | News
BioMed Realty Signs 15-Year Lease with CordenPharma Colorado for Purpose-Built Lab Facility at Flatiron Park

BioMed Realty, the largest private owner and operator of real estate for the life science, technology and innovation industries, announced that CordenPha...

March 06, 2026 | Friday | News
Sift Biosciences Raises $3.7M Pre-Seed Round to Advance AI-Driven Peptide Immunotherapy Platform

Pre-Seed Round Co-Led By Freeflow Ventures and Lifespan Vision Ventures With Participation From Valuence Ventures, Eisai Innovation, SBI US Gateway Fun...

February 20, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close